PMID- 15640395 OWN - NLM STAT- MEDLINE DCOM- 20050818 LR - 20131121 IS - 8750-7587 (Print) IS - 0161-7567 (Linking) VI - 98 IP - 5 DP - 2005 May TI - Leptin gene expression and systemic levels in healthy men: effect of exercise, carbohydrate, interleukin-6, and epinephrine. PG - 1805-12 AB - Leptin, an adipose tissue-derived cytokine, is correlated with adipose mass as obese persons have increased levels of leptin that decrease with weight loss. Previous studies demonstrate that high-energy-expenditure exercise decreases circulating leptin levels, whereas low-energy-expenditure exercise has no effect. We aimed to test the hypothesis that acute exercise reduced leptin mRNA levels in human adipose tissue and that this effect would be ameliorated by carbohydrate supplementation. Because exercise markedly increases circulating IL-6 and epinephrine, we investigated whether the changes in leptin seen with acute exercise could be mediated by IL-6 or epinephrine infusion. Abdominal subcutaneous adipose tissue mRNA and plasma levels of leptin were measured in healthy men in response to 3-h ergometer exercise with or without carbohydrate (CHO) ingestion (n = 8) and in response to infusion with recombinant human (rh)IL-6 (n = 11) or epinephrine (n = 8) or saline. Plasma leptin declined in response to exercise (P < 0.05) compared with rest, whereas mRNA expression in adipose tissue was unaffected. The exercise-induced decrease in plasma leptin was attenuated by CHO ingestion (P < 0.001). A 3-h epinephrine infusion decreased plasma leptin (P < 0.001) to the same level seen with 3 h of exercise, whereas leptin levels were unaffected by rhIL-6 infusion. In conclusion, both acute exercise and epinephrine infusion decreased plasma leptin to a similar extent, whereas there was no effect with rhIL-6 infusion. Acute exercise solely affected leptin plasma levels, as mRNA levels were unchanged. The exercise-induced decrease in circulating leptin was counteracted by CHO ingestion, suggesting a posttranscriptional regulatory mechanism of leptin involving substrate availability. FAU - Keller, Pernille AU - Keller P AD - Centre of Inflammation and Metabolism, Department of Infectious Diseases and The Copenhagen Muscle Research Center, Faculty of Health Sciences, University Hospital of Copenhagen, Denmark. FAU - Keller, Charlotte AU - Keller C FAU - Steensberg, Adam AU - Steensberg A FAU - Robinson, Lindsay E AU - Robinson LE FAU - Pedersen, Bente K AU - Pedersen BK LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20050107 PL - United States TA - J Appl Physiol (1985) JT - Journal of applied physiology (Bethesda, Md. : 1985) JID - 8502536 RN - 0 (Dietary Carbohydrates) RN - 0 (Interleukin-6) RN - 0 (Leptin) RN - 0 (RNA, Messenger) RN - 0 (Recombinant Proteins) RN - YKH834O4BH (Epinephrine) SB - IM MH - Adipose Tissue/drug effects/metabolism MH - Adult MH - Dietary Carbohydrates/*blood MH - Epinephrine/*pharmacology MH - Exercise/*physiology MH - Gene Expression Regulation/drug effects/physiology MH - Humans MH - Interleukin-6/administration & dosage/*pharmacology MH - Leptin/*biosynthesis/blood/*genetics MH - Male MH - RNA, Messenger/biosynthesis/genetics MH - Recombinant Proteins/administration & dosage/pharmacology EDAT- 2005/01/11 09:00 MHDA- 2005/08/19 09:00 CRDT- 2005/01/11 09:00 PHST- 2005/01/11 09:00 [pubmed] PHST- 2005/08/19 09:00 [medline] PHST- 2005/01/11 09:00 [entrez] AID - 00592.2004 [pii] AID - 10.1152/japplphysiol.00592.2004 [doi] PST - ppublish SO - J Appl Physiol (1985). 2005 May;98(5):1805-12. doi: 10.1152/japplphysiol.00592.2004. Epub 2005 Jan 7.